Predictive Value of Serial Measurements of sTREM-1 in the Treatment Response of Patients with Community-acquired Pneumonia

Journal of the Formosan Medical Association - Tập 106 - Trang 187-195 - 2007
Wen-Cheng Chao1, Chia-Hui Wang2, Ming-Cheng Chan1,3, Kuan-Chih Chow2, Jeng-Yuan Hsu1,4, Chieh-Liang Wu5,6,7,8
1Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taipei, Taiwan
2Department of Life Science and Graduate Institute of Biomedical Sciences, National Chung-Hsing University, Taipei, Taiwan
3Central Taiwan University of Science and Technology, Taipei, Taiwan
4Institute of Medicine, Chung-Shan Medical University, Taipei, Taiwan
5Division of Critical Care and Respiratory Therapy, Department of Internal Medicine, Taichung Veterans General Hospital, Taipei, Taiwan
6Department of Life Science, National Chung-Hsing University, Taichung, Taipei, Taiwan
7Department of Respiratory Care, Chang Jung University, Taipei, Taiwan
8National Yang-Ming University, Taipei, Taiwan

Tài liệu tham khảo

Department of Health, Executive Yuan, Republic of China. Health and Vital Statistics, 2000. Tapiei, Taiwan, R.O.C., 2001. Garibaldi, 1985, Epidemiology of community-acquired respiratory tract infections in adults. Incidence, etiology, and impact, Am J Med, 78, 32, 10.1016/0002-9343(85)90361-4 Marrie, 1989, Community-acquired pneumonia requiring hospitalization: 5-year prospective study, Reviews of infectious diseases, 11, 586, 10.1093/clinids/11.4.586 Ioanas, 2004, Causes and predictors of nonresponse to treatment of intensive care unit-acquired pneumonia, Crit Care Med, 32, 938, 10.1097/01.CCM.0000114580.98396.91 Ioanas, 2003, Treatment failures in patients with ventilator-associated pneumonia, Infect Dis Clin North Am, 17, 753, 10.1016/S0891-5520(03)00070-9 Ioanas, 2001, Evaluation of nonresponding patients with ventilator-associated pneumonia, Clin Pulm Med, 8, 290, 10.1097/00045413-200109000-00006 Tillett, 1930, Serological reactions in pneumonia with non-protein somatic fraction of pneumococcus, J Exp Med, 52, 561, 10.1084/jem.52.4.561 Smith, 1995, C-reactive protein: a clinical marker in community-acquired pneumonia, Chest, 108, 1288, 10.1378/chest.108.5.1288 Silvani, 1995, Modification of phlogosis indices in pneumonia during antibiotic therapy, Recenti Progressi in Medicina, 86, 63 Hedlund, 1995, Short- and long-term prognosis for middle-aged and elderly patients hospitalized with community-acquired pneumonia: impact of nutritional and inflammatory factors, Scand J Infect Dis, 27, 32, 10.3109/00365549509018970 Smith, 1995, C-reactive protein in simple community-acquired pneumonia, Chest, 107, 1028, 10.1378/chest.107.4.1028 Almirall, 2004, Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia, Chest, 125, 1335, 10.1378/chest.125.4.1335 Po'voa, 2005, C-reactive protein as a marker of ventilator-associated penumonia resolution: a pilot study, Eur Respir J, 25, 804, 10.1183/09031936.05.00071704 Bouchon, 2000, Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes, J Immunol, 164, 4991, 10.4049/jimmunol.164.10.4991 Bouchon, 2001, TREM-1 amplifies inflammation and is a crucial mediator of septic shock, Nature, 410, 1103, 10.1038/35074114 Gibot, 2004, Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia, N Engl J Med, 350, 451, 10.1056/NEJMoa031544 Gibot, 2004, Plasma level of a triggering receptor expressed on myeloid cells-1: its diagnostic accuracy in patients with suspected sepsis, Ann Intern Med, 141, 9, 10.7326/0003-4819-141-1-200407060-00009 Gibot, 2005, Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during sepsis, Crit Care Med, 33, 792, 10.1097/01.CCM.0000159089.16462.4A Bartlett, 2000, Practice guidelines for the management of community-acquired pneumonia in adults, Clin Infect Dis, 31, 347, 10.1086/313954 Fine, 1997, A prediction rule to identify low-risk patients with community-acquired pneumonia, N Engl J Med, 336, 243, 10.1056/NEJM199701233360402 Ros'on, 2004, Causes and factors associated with early failure in hospitalized patients with community-acquired pneumonia, Arch Intern Med, 164, 502, 10.1001/archinte.164.5.502 Lauderdale, 2005, Etiology of community acquired pneumonia among adult patients requiring hospitalization in Taiwan, Respir Med, 99, 1079, 10.1016/j.rmed.2005.02.026 Lauderdale, 2005, High carriage rate of high-level penicillin-resistant Streptococcus pneumoniae in a Taiwan kindergarten associated with a case of pneumococcal meningitis, BMC Infect Dis, 5, 96, 10.1186/1471-2334-5-96 Genn, 2003, Community-acquired pneumonia: causes of treatment failure in patients enrolled in clinical trials, Clinl Microbiol Infect, 9, 949, 10.1046/j.1469-0691.2003.00679.x Wu, 2005, Modified pneumonia severity index and length of hospital stay in patients with community-acquired pneumonia: experience of a medical center in Taiwan, Thorac Med, 20, 42 Lin, 2005, Value of the pneumonia severity index in assessment of community-acquired pneumonia, J Formos Med Assoc, 104, 164 Assicot, 1993, High serum procalcitonin concentrations in patients with sepsis and infection, Lancet, 341, 515, 10.1016/0140-6736(93)90277-N Vincent, 2000, Procalcitonin: the marker of sepsis?, Crit Care Med, 28, 1226, 10.1097/00003246-200004000-00057 Brunkhorst, 2000, Procalcitonin for early diagnosis and differentation of SIRS, sepsis, severe sepsis, and septic shock, Intensive Care Med, Supplement, 26, S148, 10.1007/s001340051134